NEWPHARMA GROUP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NEWPHARMA GROUP
Largest movements
- Intangible fixed assets +€3.2m
up €3.2m (+25,377%), from €12,499 to €3.2m
- Tangible fixed assets +€2.5m
up €2.5m (+65.1%), from €3.9m to €6.4m
of which Other tangible fixed assets: +€2.3m
- Financial fixed assets +€2.1m
up €2.1m (+2.3%), from €90.1m to €92.2m
of which Affiliated companies: +€2.1m
- Trade debts +€6.5m
up €6.5m (+314%), from €2.1m to €8.6m
- Short-term financial debts +€3.0m
new in 2026: €3.0m
- Debts after one year -€2.2m
down €2.2m (-24.5%), from €9.0m to €6.8m
- Turnover +€53.2m
up €53.2m (+684%), from €7.8m to €60.9m
- Services and other goods +€43.6m
up €43.6m (+1,016%), from €4.3m to €47.9m
- Staff costs +€7.6m
up €7.6m (+239%), from €3.2m to €10.8m
- Depreciation +€2.6m
up €2.6m (+630%), from €405,204 to €3.0m
- Goods and materials +€1.3m
new in 2026: €1.3m
of which Purchases: +€1.3m
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €101,104,339 | €108,599,500 | +€7.5m | +7.4% |
| Fixed assets | 21/28 | €94,024,336 | €101,800,944 | +€7.8m | +8.3% |
| Intangible fixed assets | 21 | €12,499 | €3,184,218 | +€3.2m | +25,377% |
| Tangible fixed assets | 22/27 | €3,873,923 | €6,394,346 | +€2.5m | +65.1% |
| Plant, machinery and equipment | 23 | - | €262,633 | +€262,633 | |
| Furniture and vehicles | 24 | €16,346 | €17,989 | +€1,643 | +10.1% |
| Other tangible fixed assets | 26 | €3,857,576 | €6,111,515 | +€2.3m | +58.4% |
| Assets under construction and advance payments | 27 | - | €2,209 | +€2,209 | |
| Financial fixed assets | 28 | €90,137,915 | €92,222,380 | +€2.1m | +2.3% |
| Affiliated companies | 280/1 | €90,137,815 | €92,222,180 | +€2.1m | +2.3% |
| Participating interests | 280 | €90,137,815 | €92,222,180 | +€2.1m | +2.3% |
| Other financial fixed assets | 284/8 | €100 | €200 | +€100 | +100% |
| Shares | 284 | €100 | €0 | -€100 | -100% |
| Amounts receivable and cash guarantees | 285/8 | - | €200 | +€200 | |
| Current assets | 29/58 | €7,080,003 | €6,798,556 | -€281,448 | -4.0% |
| Stocks and contracts in progress | 3 | - | €131,507 | +€131,507 | |
| Stocks | 30/36 | - | €131,507 | +€131,507 | |
| Raw materials and consumables | 30/31 | - | €131,507 | +€131,507 | |
| Amounts receivable within one year | 40/41 | €7,006,556 | €6,271,808 | -€734,749 | -10.5% |
| Trade receivables | 40 | €744,121 | €5,967,487 | +€5.2m | +702% |
| Other amounts receivable | 41 | €6,262,435 | €304,320 | -€6.0m | -95.1% |
| Cash at bank and in hand | 54/58 | €1,214 | €21,524 | +€20,310 | +1,673% |
| Deferred charges and accrued income | 490/1 | €72,233 | €373,718 | +€301,485 | +417% |
| Total equity and liabilities | 10/49 | €101,104,339 | €108,599,500 | +€7.5m | +7.4% |
| Equity | 10/15 | €86,703,012 | €86,262,357 | -€440,655 | -0.5% |
| Contributions | 10/11 | €86,745,274 | €86,745,274 | = | 0.0% |
| Capital | 10 | €86,745,274 | €86,745,274 | = | 0.0% |
| Issued capital | 100 | €86,745,274 | €86,745,274 | = | 0.0% |
| Reserves | 13 | - | €0 | = | |
| Non-distributable reserves | 130/1 | - | €0 | = | |
| Reserves not available under the articles | 1311 | - | €0 | = | |
| Distributable reserves | 133 | - | €0 | = | |
| Profit (loss) carried forward | 14 | -€42,262 | -€493,357 | -€451,095 | -1,067% |
| Investment grants | 15 | - | €10,440 | +€10,440 | |
| Provisions and deferred taxes | 16 | €163,444 | €93,875 | -€69,569 | -42.6% |
| Provisions for liabilities and charges | 160/5 | €163,444 | €93,875 | -€69,569 | -42.6% |
| Other liabilities and charges | 164/5 | €163,444 | €93,875 | -€69,569 | -42.6% |
| Amounts payable | 17/49 | €14,237,884 | €22,243,267 | +€8.0m | +56.2% |
| Amounts payable after more than one year | 17 | €8,987,844 | €6,788,744 | -€2.2m | -24.5% |
| Financial debts | 170/4 | €8,987,844 | €6,788,744 | -€2.2m | -24.5% |
| Other loans | 174 | €8,987,844 | €6,788,744 | -€2.2m | -24.5% |
| Amounts payable within one year | 42/48 | €5,080,397 | €15,319,812 | +€10.2m | +202% |
| Current portion of amounts payable after more than one year | 42 | €2,136,466 | €2,199,100 | +€62,635 | +2.9% |
| Financial debts | 43 | - | €3,000,132 | +€3.0m | |
| Credit institutions | 430/8 | - | €3,000,132 | +€3.0m | |
| Trade debts | 44 | €2,067,496 | €8,568,879 | +€6.5m | +314% |
| Suppliers | 440/4 | €2,067,496 | €8,568,879 | +€6.5m | +314% |
| Taxes, remuneration and social security | 45 | €669,067 | €1,546,701 | +€877,634 | +131% |
| Taxes | 450/3 | €31,066 | €76,681 | +€45,615 | +147% |
| Remuneration and social security | 454/9 | €638,001 | €1,470,020 | +€832,019 | +130% |
| Other amounts payable | 47/48 | €207,368 | €5,000 | -€202,368 | -97.6% |
| Accrued charges and deferred income | 492/3 | €169,642 | €134,711 | -€34,931 | -20.6% |
| Operating income | 70/76A | €7,920,547 | €63,542,636 | +€55.6m | +702% |
| Turnover | 70 | €7,772,440 | €60,938,545 | +€53.2m | +684% |
| Own construction capitalised | 72 | - | €2,118,733 | +€2.1m | |
| Other operating income | 74 | €148,107 | €485,358 | +€337,251 | +228% |
| Operating charges | 60/66A | €7,803,316 | €62,934,996 | +€55.1m | +707% |
| Goods for resale, raw materials and consumables | 60 | - | €1,271,769 | +€1.3m | |
| Purchases | 600/8 | - | €1,314,136 | +€1.3m | |
| Change in stocks: decrease (increase) | 609 | - | -€42,367 | -€42,367 | |
| Services and other goods | 61 | €4,293,102 | €47,929,954 | +€43.6m | +1,016% |
| Remuneration, social security and pensions | 62 | €3,188,103 | €10,799,578 | +€7.6m | +239% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €405,204 | €2,956,308 | +€2.6m | +630% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | -€85,177 | -€69,569 | +€15,609 | +18.3% |
| Other operating charges | 640/8 | €2,084 | €46,955 | +€44,872 | +2,153% |
| Operating profit (loss) | 9901 | €117,232 | €607,641 | +€490,409 | +418% |
| Financial income | 75/76B | €438,036 | €21,861 | -€416,175 | -95.0% |
| Recurring financial income | 75 | €438,036 | €21,861 | -€416,175 | -95.0% |
| Income from financial fixed assets | 750 | €188,036 | €9,417 | -€178,619 | -95.0% |
| Income from current assets | 751 | €250,000 | - | -€250,000 | |
| Other financial income | 752/9 | €0 | €12,444 | +€12,444 | |
| Financial charges | 65/66B | €593,060 | €489,031 | -€104,029 | -17.5% |
| Recurring financial charges | 65 | €593,060 | €489,031 | -€104,029 | -17.5% |
| Debt charges | 650 | €585,619 | €472,344 | -€113,274 | -19.3% |
| Other financial charges | 652/9 | €7,441 | €16,686 | +€9,245 | +124% |
| Profit (loss) for the period before taxes | 9903 | -€37,793 | €140,471 | +€178,264 | |
| Income taxes | 67/77 | €4,468 | €1,785 | -€2,683 | -60.0% |
| Taxes | 670/3 | €4,535 | €10,916 | +€6,380 | +141% |
| Tax adjustments and reversals of tax provisions | 77 | €68 | €9,131 | +€9,063 | +13,427% |
| Profit (loss) for the period | 9904 | -€42,260 | €138,686 | +€180,947 | |
| Profit (loss) for the period to be appropriated | 9905 | -€42,260 | €138,686 | +€180,947 |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.